NIH VideoCast - Charting the Path for Alzheimer's Prevention with the Colombian Kindred with Autosomal Dominant Alzheimer's Disease

Skip Navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Charting the Path for Alzheimer's Prevention with the Colombian Kindred with Autosomal Dominant Alzheimer's Disease

Loading... Loading video...

625 Views

Air date:	Wednesday, June 8, 2022, 3:00:00 PM Time displayed is Eastern Time, Washington DC Local
Views:	Total views: 625 (258 Live, 367 On-demand)
Category:	WALS - Wednesday Afternoon Lectures
Runtime:	01:04:45
Closed captioning:	Check box to display CC outside of the video Note: You can drag the captioning window around and resize it
Description:	NIH Director’s Wednesday Afternoon Lecture Series Florence Mahoney Lecture on Aging. Quiroz will discuss how longitudinal studies conducted with Colombian families with autosomal dominant Alzheimer's disease have informed biomarker research, disease prevention, and treatment development. An associate professor in the Departments of Psychiatry and Neurology at Massachusetts General Hospital, Harvard Medical School, Quiroz currently serves as director of the MGH Multicultural Assessment and Research Center and the Multicultural Alzheimer's Prevention Program-MAPP. She is also principal investigator on the NIH-funded COLBOS (COLombia-BOSton) biomarker study that follows individuals from the world's largest extended family with a single, Alzheimer's-causing mutation (E280A in Presenilin1). Her findings have helped researchers re-conceptualize Alzheimer's as a sequence of changes that begins decades before cognitive decline, and which may be targeted by promising disease-slowing treatments and prevention strategies at a time in which they might have their most profound effect. Quiroz hails from Colombia, South America, where she earned her bachelor's degree from the University of Antioquia, Medellin, Colombia. She also holds a Master's in Cognitive Neuroscience and Ph.D. in Clinical Psychology, both from Boston University. Her postdoctoral training was in Clinical Neuropsychology, Department of Neurology and Psychiatry, at Massachusetts General Hospital; where she joined the faculty of Harvard Medical School/Massachusetts General Hospital where she remains. Quiroz has been recognized broadly for her research, including with the NIH Director's Early Independence Award, an MGH Research Scholar Award, and the Alzheimer' Association's Inge Grundke-Iqbal Award for Alzheimer's Research. The NIH Mahoney lecture is named in honor of Florence Stephenson Mahoney (1899–2002), who devoted much of her life to successfully advocating for the creation of NIA and increased support for NIH. For more information go to https://oir.nih.gov/wals

NLM Title:	Charting the path for Alzheimer's prevention with the Colombian kindred with autosomal dominant Alzheimer's disease / Yakeel T. Quiroz.
Author:	Quiroz, Yakeel T. National Institutes of Health (U.S.),
Publisher:
Abstract:	(CIT): NIH Director's Wednesday Afternoon Lecture Series Florence Mahoney Lecture on Aging. Quiroz will discuss how longitudinal studies conducted with Colombian families with autosomal dominant Alzheimer's disease have informed biomarker research, disease prevention, and treatment development. An associate professor in the Departments of Psychiatry and Neurology at Massachusetts General Hospital, Harvard Medical School, Quiroz currently serves as director of the MGH Multicultural Assessment and Research Center and the Multicultural Alzheimer's Prevention Program-MAPP. She is also principal investigator on the NIH-funded COLBOS (COLombia-BOSton) biomarker study that follows individuals from the world's largest extended family with a single, Alzheimer's-causing mutation (E280A in Presenilin1).Her findings have helped researchers re-conceptualize Alzheimer's as a sequence of changes that begins decades before cognitive decline, and which may be targeted by promising disease-slowing treatments and prevention strategies at a time in which they might have their most profound effect. Quiroz hails from Colombia, South America, where she earned her bachelor's degree from the University of Antioquia, Medellin, Colombia. She also holds a Master's in Cognitive Neuroscience and Ph.D. in Clinical Psychology, both from Boston University. Her postdoctoral training was in Clinical Neuropsychology, Department of Neurology and Psychiatry, at Massachusetts General Hospital; where she joined the faculty of Harvard Medical School/Massachusetts General Hospital where she remains. Quiroz has been recognized broadly for her research, including with the NIH Director's Early Independence Award, an MGH Research Scholar Award, and the Alzheimer" Association's Inge Grundke-Iqbal Award for Alzheimer's Research. The NIH Mahoney lecture is named in honor of Florence Stephenson Mahoney (1899-2002), who devoted much of her life to successfully advocating for the creation of NIA and increased support for NIH. For more information go to https://oir.nih.gov/wals.
Subjects:	Alzheimer Disease--genetics Alzheimer Disease--prevention & control Colombia--epidemiology Early Medical Intervention Genetic Markers Longitudinal Studies
Publication Types:	Lecture Webcast

NLM Classification:	WT 160
NLM ID:	9918434185706676
CIT Live ID:	44272
Permanent link:	https://videocast.nih.gov/watch=44272

Related Videos...